Inventor
Luca Gianni
Inventor
Milan, IT
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations35%
A61KPreparations for medical, dental or toiletry purposes24%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests18%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms12%
G01NInvestigating or analysing materials by determining their chemical or physical properties12%
PatentTitleYear
9,605,318'Gene expression markers for predicting response to chemotherapy'20177,871,769'Gene expression markers for predicting response to chemotherapy'20117,700,613'Use of 7-t-butoxyiminomethylcamptothecin for the preparation of a medicament for the treatment of uterine neoplasms'20106,927,211'Method for reducing toxicity of combined chemotherapies'20056,906,040'Method for reducing toxicity of combined chemotherapies'20055,637,572'Use of 4\'-iodo-4\'-deoxydoxorubicin for the treatment of amyloidosis'1997Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1997–2017Based in Milan, IT· patent location history
2005Patents assigned to BRISTOL MYERS SQUIBB CO (2)· patent assignee history
2011–2017Patents assigned to GENOMIC HEALTH INC (2)· patent assignee history
2011Patents assigned to INST NAZ TUMORI (1)· patent assignee history
2017Patents assigned to BAKER JOFFRE B (1)· patent assignee history
2017Patents assigned to GIANNI LUCA (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BRISTOL MYERS SQUIBB CO | 2 | 2005 |
| GENOMIC HEALTH INC | 2 | 2011–2017 |
| BAKER JOFFRE B | 1 | 2017 |
| GIANNI LUCAself | 1 | 2017 |
| INST NAZ TUMORI | 1 | 2011 |
Locations
| Location | Patents | Span |
|---|---|---|
| Milan, IT | 6 | 1997–2017 |